Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis.Christopher Holroyd, Christopher J Edwards, Caron Underhill et al.|PubMed|2018Cited by 17
O52 Switching to Biosimilar Infliximab: Real-World Data from the Southampton Biologic Therapies Review ServiceChristopher Holroyd, Christopher J Edwards, Lucy Anne Parker et al.|Lara D. Veeken|2016Cited by 12